Clinical Trials Logo

Stroke clinical trials

View clinical trials related to Stroke.

Filter by:

NCT ID: NCT04876339 Recruiting - Stroke Clinical Trials

Sonification Techniques for Gait Training

SonicWalk
Start date: January 18, 2021
Phase: N/A
Study type: Interventional

Music therapy is widely used in relational and rehabilitation settings. In addition to Neurologic Music Therapy and other music-based techniques, "sonification" approaches were recently introduced in the field of rehabilitation. The "sonification" can be defined as a properly selected set of sonorous-music stimuli are associated with patient movements mapping. In fact, the auditory-motor feedback can replace damaged proprioceptive circuits with a consequent improvement of the rehabilitation process. Interventions with "sonification" facilitate sensorimotor learning, proprioception and movements planning and execution improving global motor parameters. This study proposes the use of musical auditory cues which includes the melodic-harmonic component of the music. This kind of sonification makes the feedback pleasant and predictable as well as potentially effective. The investigators propose to apply and assess the effectiveness of this kind of sonification on gait training and other secondary outcomes in stroke, Parkinson's disease and multiple sclerosis population. Also, the investigators will assess the impact of "sonification" on the level of fatigue perceived during the rehabilitation process and on the quality of life. The study is a multicenter randomized controlled trial and will involve 120 patients that will undergo standard motor rehabilitation or the same rehabilitation but with the sonification support. The interventions will be evaluated at the baseline, after 10 sessions, after 20 sessions and at follow-up (one month after the end of the treatment). The assessment will include functional, motor, fatigue and quality of life evaluations. The collected data will be statistically processed.

NCT ID: NCT04876066 Recruiting - Clinical trials for Post-stroke Depression

Use of Transmucosal Ketamine in Post Stroke Depression

Start date: November 30, 2020
Phase: Phase 1
Study type: Interventional

Studies have shown that ketamine is very effective and has a quick onset in treatment of depression. Most of these studies used intravenous ketamine in an inpatient setting and there are no large trials examining its use in Post Stroke Depression (PSD). There have been only few studies that have used other routes of administration (i.e., oral, transmucosal, intranasal, intramuscular) of ketamine which provided symptom relief for depression. The purpose of this study is to assess the effectiveness and safety of use of transmucosal ketamine in treatment of PSD. We hypothesize that fast acting antidepressant effects can be achieved with tolerable side effects for translation into the general post-stroke population. To test our hypothesis, the specific aim is to: (1) demonstrate that transmucosal administration of ketamine is feasible within the post-stroke depression population and has tolerable side effects. Exploratory aims will include assessment if ketamine also produces fast acting antidepressant effects.

NCT ID: NCT04875936 Recruiting - Stroke Clinical Trials

Neurofeedback Intervention for Reading Deficits in Subacute Stroke

ReadingNFB
Start date: April 3, 2023
Phase: N/A
Study type: Interventional

The overall goal of this project is to advance a biologically-based approach to treatment of reading disorders after stroke, which will expand the limits of cognitive rehabilitation. Using a novel brain imaging technique, called real-time functional magnetic resonance imaging (fMRI) neurofeedback combined with right hand motor imagery, this project will re-instate brain activity in the left language-dominant hemisphere. Stroke patients will practice modulating their own brain activity using fMRI neurofeedback signal and will select the most effective mental strategies that help them maintain brain activation patterns associated with better reading recovery.

NCT ID: NCT04875910 Completed - Stroke Clinical Trials

Effectiveness of Telerehabilitation in Improving Walking and Balance Among Stroke Survivors?

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

A good rehabilitation program may not be accessible for all individuals living with stroke due to cost, transportation and compliance. Telerehabilitation is an alternative health care program that may help in overcoming this issue. In this study we aim to find if the use of telerehabilitation in Saudi Arabia would improve balance and walking in stroke survivors during this pandemic.

NCT ID: NCT04874454 Recruiting - Acute Stroke Clinical Trials

Evaluating Potential Risk of Choking by Laryngeal Ultrasound in Patients With Acute Stroke

Start date: July 14, 2023
Phase: N/A
Study type: Interventional

The investigators evaluate the vocal cord movement in patients with acute stroke by ultrasound. The occurrence of choking or aspiration pneumonia will be collected in one year after the index stroke.

NCT ID: NCT04874181 Completed - Stroke, Acute Clinical Trials

Use of Virtual Reality Game in Rehabilitation of Stroke Patients in Tan Tock Seng Hospital

Start date: July 27, 2020
Phase: N/A
Study type: Interventional

Use of SIlverfit 3d to aid in rehab of stroke patients focusing on their shoulder and knee strength

NCT ID: NCT04874051 Recruiting - Stroke Clinical Trials

Sensor-based Assessment and Rehabilitation of Balance in Neurological Diseases

BALANCE
Start date: September 2, 2019
Phase: N/A
Study type: Interventional

Balance impairment is one of the most common disorders due to a neurological diseases. Sensor-based technologies may be useful for falls prevention and balance recovery during patients hospitalization. OAK Elderly Care System (Khymeia Group, Noventa Padovana, Italy) allows the assessment of fall risk, the centre of pressure and the execution of balance exercises in a virtual environment.

NCT ID: NCT04873908 Completed - Stroke Clinical Trials

Effects of Modified Constraint-Induced on Chronic Stroke Patients

Start date: May 5, 2021
Phase: N/A
Study type: Interventional

In the present study, it was aimed to compare the proprioception training applied in addition to conventional treatment and Modified Constraint-Induced Movement Therapy treatment in patients with chronic strokes and to investigate the effects on proprioception, spasticity, functional motor skills and daily living activities in the upper extremity.

NCT ID: NCT04873583 Recruiting - Paediatric Stroke Clinical Trials

High Dose Steroids in Children With Stroke

PASTA
Start date: November 16, 2021
Phase: Phase 3
Study type: Interventional

This clinical trial deals with focal cerebral arteriopathy and childhood stroke, a rare but devastating condition. Focal cerebral arteriopathy (FCA) is an inflammatory vessel wall disease provoked by infection and there is increasing evidence that inflammatory processes play a crucial role in childhood stroke, influencing the outcome of the disease. Analysis of existing data suggests that outcomes are improved and that there is less stroke recurrence in children treated with steroids to reduce the acute inflammatory processes. This clinical trial will be conducted in over 20 hospitals in several countries in order to investigate this. Participants will be randomly separated into two groups. The first group will be treated with standard of care (including aspirin) combined with high dose steroids. The second group will be treated with standard of care (including aspirin) but without steroid treatment. The objective is to investigate if children treated with a combination of high dose steroid and aspirin will have a better and quicker recovery of FCA, better clinical functional outcome, and less recurrence compared to children treated with aspirin alone. This project has been identified by international pediatric stroke experts as the most important topic for a clinical trial in the field and is as well one of the most important research priorities identified by parents. The study results will also provide insight into the evolution of inflammatory vessel disease.

NCT ID: NCT04873297 Completed - Acute Stroke Clinical Trials

Metoclopramide vs Placebo for Prevention of Pneumonia in Acute Stroke

Start date: May 2, 2021
Phase: Phase 4
Study type: Interventional

Pneumonia is a major cause of mortality and morbidity in patients with acute stroke fed via nasogastric tubes and may be because of vomiting and gastro-esophageal regurgitation. The aim of the study was to assess whether regular treatment with metoclopramide, a D2-receptor antagonist with antiemetic and gastric prokinetic actions, could reduce the rate of pneumonia.